Occlutech ASD Occluder​ Designed for safety and excellence

0closure
97,3% closure rate, with an excellent outcome during the 12-month follow-up period.
0reduced time
Procedure and fluoroscopic time is reduced by 34% compared to other devices.
0 countries
83,000 ASD occluders have been delivered to over 70 countries around the world

The design of the Occlutech ASD Occluder results in a septum alignment which increases its feasibility and patient safety during implantation.1 Recent studies found that transcatheter closure of isolated secundum atrial septal defects using the novel design of the Occlutech ASD Occluder was safe, effective and had a closure rate of 97.3 % with an excellent outcome during the 12-month follow-up period.2,3 

Product features

  • New generation has optimized braiding pattern and less material at left atrial disc.
  • The Occlutech ASD Occluder has a titanium oxide layer to reduce nickel leaching.4,5
  • Spunbonded polyester patch facilitates endotheliaziation.
  • The unique ball-connection between pusher and occluder safely locks it, while it freely follows the anatomy. Once in place it is easy and quick to deliver.

Clinical benefits

  • New generation has lower pull in forces and improved delivery sheath compatibility.7
  • Reduced material exposure.7
  • Significantly reduced mean procedure and fluoroscopic time compared to other devices (34%).

The Flex II ASD has not received FDA Premarket Approval. 

Optimal material and Design characteristics8

asd design

Product Instructions for Use

Looking for the user instructions
for our occluders and AFR?

Live Cases

Watch live cases of implantations
and placements of our occluders.

Publications

Get the latest documentation
regarding our occluders and AFR. 

This movie is showing in a general way how an Occlutech ASD Occluder is implanted

3D TEE image of an implanted Occlutech
ASD Occluder.

Perfect alignment of the Occluder to the Septum.9

50° angulation of Flex Pusher vs Occluder hub.

Content references:
  1. Catheter Cardiovasc Interv. 2008 Krizanic F Optimal septum alignment of the Figulla® Flex occluder to the atrial septum in patients with secundum atrial septal defects
  2. Archives of Cardiovascular Diseases 2011
    Cansel M Early single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adults.
  3. Haas NA et.al. Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients:
    The IRFACODE Project: A Retrospective Case Series.
  4. 2019_Bhattacharjya_prospective-concurrent-head-to-head-comparison-of-three-different-types-of-ASDs
  5. ASD_ALL_TRM_ver05
  6. 2018_Kenny A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to
    the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects
  7. ASD_ALL_PD_vers04
  8. 2013_Zuh_Oxidation of Nitinol and its Effect on Corrosion Resistance
  9. P17F02.030.04